|
1
|
Long-term use of ticagrelor in patients with prior myocardial infarction.
|
N Engl J Med
|
2015
|
8.69
|
|
2
|
Clopidogrel with or without omeprazole in coronary artery disease.
|
N Engl J Med
|
2010
|
7.39
|
|
3
|
Rivaroxaban in patients with a recent acute coronary syndrome.
|
N Engl J Med
|
2011
|
7.30
|
|
4
|
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
|
N Engl J Med
|
2006
|
5.07
|
|
5
|
Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial.
|
JAMA
|
2011
|
3.28
|
|
6
|
Rheumatoid arthritis-interstitial lung disease-associated mortality.
|
Am J Respir Crit Care Med
|
2010
|
3.05
|
|
7
|
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
|
JAMA
|
2004
|
2.89
|
|
8
|
A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial.
|
Circ Heart Fail
|
2011
|
2.15
|
|
9
|
The use of virtual patients to teach medical students history taking and communication skills.
|
Am J Surg
|
2006
|
1.84
|
|
10
|
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.
|
Lancet
|
2011
|
1.80
|
|
11
|
Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry.
|
J Am Coll Cardiol
|
2003
|
1.68
|
|
12
|
Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
|
Catheter Cardiovasc Interv
|
2002
|
1.66
|
|
13
|
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.
|
JACC Cardiovasc Interv
|
2009
|
1.56
|
|
14
|
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.
|
JAMA
|
2005
|
1.52
|
|
15
|
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis.
|
BMJ
|
2012
|
1.51
|
|
16
|
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
|
J Am Coll Cardiol
|
2007
|
1.51
|
|
17
|
Analysis of particulate debris after superficial femoral artery atherectomy.
|
J Invasive Cardiol
|
2009
|
1.50
|
|
18
|
Pitfalls associated with the use of current recommendations for fluoroscopy-guided common femoral artery access.
|
Catheter Cardiovasc Interv
|
2013
|
1.47
|
|
19
|
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY.
|
Int J Cardiol
|
2009
|
1.45
|
|
20
|
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial.
|
JAMA
|
2013
|
1.45
|
|
21
|
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.
|
JAMA
|
2004
|
1.44
|
|
22
|
Internet-based health promotion and disease control in the 8 cities: successes, barriers, and future plans.
|
Sex Transm Dis
|
2005
|
1.41
|
|
23
|
Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.
|
Am Heart J
|
2003
|
1.21
|
|
24
|
DNA damage and repair in human oocytes and embryos: a review.
|
Zygote
|
2010
|
1.11
|
|
25
|
Yoga in Australia: Results of a national survey.
|
Int J Yoga
|
2012
|
1.07
|
|
26
|
Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial.
|
J Thorac Cardiovasc Surg
|
2002
|
1.05
|
|
27
|
Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery.
|
Ann Thorac Surg
|
2002
|
1.05
|
|
28
|
C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression.
|
Proc Natl Acad Sci U S A
|
2005
|
1.04
|
|
29
|
Do medical students respond empathetically to a virtual patient?
|
Am J Surg
|
2007
|
1.04
|
|
30
|
Staphylococcus capitis prosthetic valve endocarditis: report of two rare cases and review of literature.
|
Heart Lung
|
2008
|
0.97
|
|
31
|
Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention.
|
Int J Cardiol
|
2010
|
0.95
|
|
32
|
Yoga and hypertension: a systematic review.
|
Altern Ther Health Med
|
2014
|
0.91
|
|
33
|
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study.
|
J Am Coll Cardiol
|
2003
|
0.90
|
|
34
|
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
|
Am Heart J
|
2006
|
0.89
|
|
35
|
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.
|
Catheter Cardiovasc Interv
|
2007
|
0.89
|
|
36
|
Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
|
Am Heart J
|
2003
|
0.89
|
|
37
|
Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51.
|
J Am Coll Cardiol
|
2013
|
0.88
|
|
38
|
Efficacy and Safety of a Chinese Herbal Medicine Formula (RCM-104) in the Management of Simple Obesity: A Randomized, Placebo-Controlled Clinical Trial.
|
Evid Based Complement Alternat Med
|
2012
|
0.87
|
|
39
|
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.
|
Eur Heart J
|
2007
|
0.87
|
|
40
|
Uptake and impact of research for evidence-based practice: lessons from the Africa Health Systems Initiative Support to African Research Partnerships.
|
BMC Health Serv Res
|
2014
|
0.87
|
|
41
|
The practice and regulatory requirements of naturopathy and western herbal medicine in Australia.
|
Risk Manag Healthc Policy
|
2009
|
0.86
|
|
42
|
Molecular effects of fractional carbon dioxide laser resurfacing on photodamaged human skin.
|
Arch Facial Plast Surg
|
2010
|
0.86
|
|
43
|
Garlic for the common cold.
|
Cochrane Database Syst Rev
|
2009
|
0.85
|
|
44
|
Autism, imprinting and epigenetic disorders: a metabolic syndrome linked to anomalies in homocysteine recycling starting in early life??
|
J Assist Reprod Genet
|
2011
|
0.85
|
|
45
|
Effect of antioxidants on sperm genetic damage.
|
Adv Exp Med Biol
|
2014
|
0.85
|
|
46
|
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial.
|
Eur Heart J
|
2008
|
0.85
|
|
47
|
Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction.
|
Am J Cardiol
|
2013
|
0.84
|
|
48
|
In-hospital mortality associated with the use of intra-aortic balloon counterpulsation.
|
Am J Cardiol
|
2004
|
0.84
|
|
49
|
Relationships between measures of dysfunctional breathing in a population with concerns about their breathing.
|
J Bodyw Mov Ther
|
2010
|
0.84
|
|
50
|
Relationship between dysfunctional breathing patterns and ability to achieve target heart rate variability with features of "coherence" during biofeedback.
|
Altern Ther Health Med
|
2011
|
0.83
|
|
51
|
Evaluation of breathing pattern: comparison of a Manual Assessment of Respiratory Motion (MARM) and respiratory induction plethysmography.
|
Appl Psychophysiol Biofeedback
|
2008
|
0.83
|
|
52
|
Identification of patients at high risk for death and cardiac ischemic events after hospital discharge.
|
Am Heart J
|
2002
|
0.82
|
|
53
|
Characteristics and consumption patterns of Australian organic consumers.
|
J Sci Food Agric
|
2012
|
0.82
|
|
54
|
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
|
J Gen Intern Med
|
2008
|
0.82
|
|
55
|
Garlic for the common cold.
|
Cochrane Database Syst Rev
|
2014
|
0.82
|
|
56
|
Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
|
Am Heart J
|
2008
|
0.81
|
|
57
|
Addressing the human resources for health crisis through task-shifting and retention: results from the Africa Health Systems Initiative Support to African Research Partnerships program.
|
Hum Resour Health
|
2014
|
0.81
|
|
58
|
Yoga for improving sleep quality and quality of life for older adults.
|
Altern Ther Health Med
|
2014
|
0.81
|
|
59
|
Radiologic measurement of submandibular gland ptosis.
|
Facial Plast Surg
|
2013
|
0.81
|
|
60
|
Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy.
|
Curr Med Res Opin
|
2006
|
0.81
|
|
61
|
The use of a HEMOCHRON JR. HEMONOX point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures.
|
J Thromb Thrombolysis
|
2006
|
0.81
|
|
62
|
Garlic for the common cold.
|
Cochrane Database Syst Rev
|
2012
|
0.81
|
|
63
|
Sperm nucleus decondensation, hyaluronic acid (HA) binding and oocyte activation capacity: different markers of sperm immaturity? Case reports.
|
J Assist Reprod Genet
|
2012
|
0.80
|
|
64
|
The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy.
|
Am Heart J
|
2006
|
0.80
|
|
65
|
Balancing myocardial ischemic and bleeding risks in patients with non-ST-segment elevation myocardial infarction.
|
Am J Cardiol
|
2009
|
0.80
|
|
66
|
The anatomy of nasopharyngeal carcinoma spread through the pharyngobasilar fascia to the trigeminal mandibular nerve on 1.5 T MRI.
|
Surg Radiol Anat
|
2010
|
0.79
|
|
67
|
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial.
|
Circulation
|
2002
|
0.79
|
|
68
|
Randomized trial of tacrolimus monotherapy: tacrolimus in combination, tacrolimus alone compared (the TICTAC trial).
|
J Heart Lung Transplant
|
2007
|
0.79
|
|
69
|
Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention.
|
Am J Cardiol
|
2002
|
0.79
|
|
70
|
Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen.
|
J Thromb Thrombolysis
|
2008
|
0.79
|
|
71
|
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial).
|
Am J Cardiol
|
2013
|
0.79
|
|
72
|
Preoperative IABP in high-risk patients reduces postoperative lactate release and subsequent mortality.
|
Ann Thorac Surg
|
2002
|
0.78
|
|
73
|
Surgical treatment of a clival-C2 atypical teratoid/rhabdoid tumor.
|
J Neurosurg Pediatr
|
2010
|
0.78
|
|
74
|
Platelets and antiplatelet therapy in patients with diabetes mellitus.
|
J Invasive Cardiol
|
2003
|
0.78
|
|
75
|
Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies.
|
J Am Coll Cardiol
|
2003
|
0.78
|
|
76
|
Malonaldehyde formation and DNA fragmentation: two independent sperm decays linked to reactive oxygen species.
|
Zygote
|
2010
|
0.78
|
|
77
|
Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus.
|
Am Heart J
|
2002
|
0.78
|
|
78
|
A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial.
|
Am Heart J
|
2011
|
0.78
|
|
79
|
Interatrial thrombus-in-transit resulting in paradoxical thromboembolism.
|
J Thromb Thrombolysis
|
2009
|
0.78
|
|
80
|
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis.
|
Vasc Health Risk Manag
|
2012
|
0.78
|
|
81
|
Association of carotid artery intima-media thickness with complex aortic atherosclerosis in patients with recent stroke.
|
Angiology
|
2002
|
0.78
|
|
82
|
The importance of the one carbon cycle nutritional support in human male fertility: a preliminary clinical report.
|
Reprod Biol Endocrinol
|
2014
|
0.78
|
|
83
|
Disease relapse after segmental resection and free flap reconstruction for mandibular osteoradionecrosis.
|
Otolaryngol Head Neck Surg
|
2010
|
0.78
|
|
84
|
Assessing diet as a modifiable risk factor for pesticide exposure.
|
Int J Environ Res Public Health
|
2011
|
0.77
|
|
85
|
Enoxaparin: a pharmacologic and clinical review.
|
Expert Opin Pharmacother
|
2011
|
0.77
|
|
86
|
Use of complementary medicines by cardiac surgery patients; undisclosed and undetected.
|
Heart Lung Circ
|
2011
|
0.76
|
|
87
|
Investigating the claims of Konstantin Buteyko, M.D., Ph.D.: the relationship of breath holding time to end tidal CO2 and other proposed measures of dysfunctional breathing.
|
J Altern Complement Med
|
2008
|
0.76
|
|
88
|
Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report.
|
J Invasive Cardiol
|
2006
|
0.76
|
|
89
|
Unfractionated versus fractionated heparin for percutaneous coronary intervention.
|
Curr Cardiol Rep
|
2002
|
0.76
|
|
90
|
Exploring the other side of acupuncture.
|
J Altern Complement Med
|
2006
|
0.75
|
|
91
|
Utility of carotid duplex ultrasonography in a general inner-city hospital.
|
Cardiovasc Ultrasound
|
2014
|
0.75
|
|
92
|
Response to "Parathyroid Surgery: Getting It Right the First Time": Parathyroid Surgery: Primum Non Nocere.
|
Otolaryngol Head Neck Surg
|
2016
|
0.75
|
|
93
|
Appropriate anti-thrombotic/anti-thrombin therapy for thrombotic lesions.
|
Curr Cardiol Rev
|
2012
|
0.75
|
|
94
|
Progress with diabetic patients undergoing percutaneous coronary intervention.
|
Eur Heart J
|
2004
|
0.75
|
|
95
|
Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation.
|
Thromb Haemost
|
2002
|
0.75
|
|
96
|
Acute coronary syndromes: from the emergency department to the catheterization laboratory-integrating evidence from recent ACS/NSTEMI trials into clinical practice: an evidence-based review of recent clinical trial results and report on a roundtable discussion.
|
J Interv Cardiol
|
2010
|
0.75
|
|
97
|
The sustainable training, treatment, employment program model: effects of manual therapy on musculoskeletal pain and limitation in a Filipino squatter community.
|
J Manipulative Physiol Ther
|
2011
|
0.75
|
|
98
|
[7/12. Organizing the therapeutic day].
|
Soins Gerontol
|
2011
|
0.75
|
|
99
|
Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Low-Intermediate Surgical Risk Patients: A Systematic Review and Meta-Analysis.
|
J Invasive Cardiol
|
2017
|
0.75
|
|
100
|
Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status.
|
Thromb Haemost
|
2017
|
0.75
|
|
101
|
Percutaneous treatment of stent-graft (viabahn) thrombosis employing a second stent-graft.
|
J Invasive Cardiol
|
2015
|
0.75
|
|
102
|
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin.
|
J Thromb Thrombolysis
|
2012
|
0.75
|
|
103
|
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library.
|
Am Heart J
|
2004
|
0.75
|
|
104
|
Impact of Coronary Artery Disease on Postoperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR): Is Preoperative Coronary Revascularization Necessary?
|
J Invasive Cardiol
|
2016
|
0.75
|
|
105
|
Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
|
J Invasive Cardiol
|
2004
|
0.75
|
|
106
|
ED to catheterization laboratory: a roundtable integrating trials with practice.
|
Am J Emerg Med
|
2010
|
0.75
|
|
107
|
The impact of postrandomization crossover of therapy in acute coronary syndromes care.
|
Circ Cardiovasc Qual Outcomes
|
2011
|
0.75
|
|
108
|
Differences among low-molecular-weight heparins: evidence in patients with acute coronary syndromes.
|
J Cardiovasc Pharmacol
|
2009
|
0.75
|
|
109
|
Emerging antithrombotic agents: what does the intensivist need to know?
|
Curr Opin Crit Care
|
2010
|
0.75
|
|
110
|
Feasibility of the 3D RCA catheter to engage the brachiocephalic vessels during carotid angiography and stenting.
|
Catheter Cardiovasc Interv
|
2010
|
0.75
|
|
111
|
Totally Percutaneous Insertion and Removal of Impella Device Using Axillary Artery in the Setting of Advanced Peripheral Artery Disease.
|
J Invasive Cardiol
|
2016
|
0.75
|
|
112
|
Early ambulation and variability in anticoagulation during elective coronary stenting with a single intravenous bolus of low-dose, low-molecular weight heparin enoxaparin.
|
J Invasive Cardiol
|
2006
|
0.75
|
|
113
|
Hypertrophic obstructive cardiomyopathy in the era of cardiac MRI.
|
J Invasive Cardiol
|
2004
|
0.75
|
|
114
|
Reply: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet Treatment.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
115
|
Expert consensus on treatment strategies in non- ST-segment elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention--an evidence-based review of clinical trial results and treatment guidelines from an emergency medicine perspective: report on a roundtable discussion.
|
Am J Emerg Med
|
2009
|
0.75
|
|
116
|
The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.
|
Am Heart J
|
2008
|
0.75
|